Application Note | August 12, 2014

Analysis Of Tricyclic Antidepressants In Human Urine Using Convergence Chromatography (UPC2)

Source: Waters Corporation
WatersCorp

By Erin Chambers and Kenneth J Fountain, Waters Corporation

Charaterized by the use of an environmentally sustainable, renewable primary solvent (CO2), orthogonality to reversed phase chromatography, and availability of diverse stationary phases, UPC2 provides the benefits of reduced solvent consumption and cost, increased bioanalytical method selectivity, and flexibility in method development.

For full access to this content, please Register or Sign In.

Access Content Analysis Of Tricyclic Antidepressants In Human Urine Using Convergence Chromatography (UPC2)
Newsletter Signup
Newsletter Signup
Get the latest industry news, insights, and analysis delivered to your inbox.
Join your peers
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.